1
|
Tougeron D, Michel P, Lièvre A, Ducreux M, Gaujoux S, Guiu B, Huguet F, Lecomte T, Lepage C, Louvet C, Maggiori L, Mariani P, Aparicio T, Bouché O. Management of digestive cancers during the COVID-19 second wave: A French intergroup point of view (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFR). Dig Liver Dis 2021; 53:306-308. [PMID: 33341421 PMCID: PMC7836265 DOI: 10.1016/j.dld.2020.11.029] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/24/2020] [Accepted: 11/25/2020] [Indexed: 12/11/2022]
Abstract
INTRODUCTION The COVID-19 pandemic has major impact of healthcare systems, including cancer care pathways. The aim of this work is to discuss in a multidisciplinary approach the therapeutic and/or strategies adaptations for patients treated for a digestive cancer during the European second wave of COVID-19 pandemic. METHODS A collaborative work was performed by several French societies to answer how to preserve digestive cancer care with no loss of chance during the second wave of COVID-19. In this context, all recommendations are graded as expert's agreement according to level evidence found in literature until October 2020 and the experience of the first wave of the COVID-19 pandemic. RESULTS As far as possible, no therapeutic modification should be carried out. If necessary, therapeutic adjustments may be considered if they do not constitute a loss of chance for patients. Considering the level of evidence all therapeutic modifications need to be discussed in multidisciplinary tumor board meeting and with patient consent. By contrast to first wave cancer prevention, cancer screening, supportive care and clinical trials should be continued. CONCLUSION Recommendations proposed could limit cancer excess mortality due to the COVID-19 pandemic but should be adapted according to the situation in each hospital.
Collapse
Affiliation(s)
- David Tougeron
- Gastroenterology and Hepatology Department, Poitiers University Hospital, University of Poitiers, Poitiers, France,Corresponding author
| | - Pierre Michel
- Normandie University, UNIROUEN, Inserm U1245, IRON Group, Rouen University Hospital, Gastroenterology and Hepatology Department, Rouen, France
| | - Astrid Lièvre
- Rennes 1 University, Rennes, France, Gastroenterology Department, Pontchaillou University Hospital, Rennes, France, INSERM UMR 1242, COSS "Chemistry, Oncogenesis, Stress Signaling", Rennes, France, Centre Régional de Coordination des Dépistage des Cancers, antenne d'Ille-et-Vilaine (Adeci 35), France
| | - Michel Ducreux
- Digestive Oncology Department, Gustave Roussy Institut, Villejuif, Paris-Saclay University, France
| | - Sébastien Gaujoux
- Digestive Surgical Department, Pitié-Salpêtrière University Hospital, Paris, France
| | - Boris Guiu
- Radiology Department, Montpellier University Hospital, Montpellier, France
| | - Florence Huguet
- Radiotherapy Department, Tenon University Hospital, Institut Universitaire de Canécrologie, APHP, Sorbonne University, Paris, France
| | - Thierry Lecomte
- Gastroenterology, Digestive Oncology and Hepatology Department, Tours University Hospital, UMR INSERM 1069 N2C, Tours University, Tours, France
| | - Côme Lepage
- Gastroenterology and Hepatology Department, Le Bocage University Hospital, EPICAD INSERM LNC-UMR 1231, Bourgogne and Franche Comté University, Dijon, France
| | - Christophe Louvet
- Medical Oncology Department, Mutualiste Montsouris Institut, Paris, France
| | - Léon Maggiori
- Digestive Surgery Department, St Louis University Hospital, Paris, France
| | - Pascale Mariani
- Oncologic Digestive Surgery Department, Curie Institut, Paris, France
| | - Thomas Aparicio
- Gastroenterology and Digestive Oncology Department, Saint Louis Hospital, APHP, Nord, Université de Paris, Paris
| | - Olivier Bouché
- Digestive Oncology Department, Reims University Hospital, Reims, France
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|